Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Álava is a privately held Spanish industrial technology and engineering group that provides advanced hardware, software, and technical services across multiple sectors, including aerospace, defense, energy, infrastructure, laboratories, and pharmaceutical/biotech environments. The company focuses on instrumentation, sensing, scientific imaging, spectroscopy, predictive maintenance, industrial monitoring, cleanroom and laboratory-related solutions, and related consulting and support services. In pharma and biotech, it appears to act primarily as a technology supplier and strategic service partner rather than as a therapeutics developer, offering tools for process optimization, quality control, environmental monitoring, traceability, and laboratory operations. The group has more than 50 years of operating history and is headquartered in Madrid, with international activity through affiliates such as Alava International. Overall, Grupo Álava should be classified as an industrial/lab technology company with healthcare-adjacent exposure, not a biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Álava.